Tradestie Institutional Equity Comparison Engine
GRX vs GUT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
GRX Overall Edge
GRX Captures Institutional Edge (1โ0 Pillars ยท 3โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to The Gabelli Healthcare & Wellness Trust (GRX) driven by superior Momentum & Technical. Fundamentally, GRX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus GUT at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, GRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GUT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
GRX N/M vs GUT N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
GRX
1Y +11.5% vs -14.6% ยท 52W Pos 91% vs 8%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
GRX
NYSE
The Gabelli Healthcare & Wellness Trust
Institutional Equity
$10.58
+1.63% 1D
Market Cap
$142.9M
1M Return
+4.86%
1Y Return
+11.49%
Forward P/E
N/M
Unified AI Score
44.3 / 100
HOLD
Tech 29.0
Fund 44.0
Flow 50.0
Mom 56.2
GUT
NYSE
Gabelli Utility Trust
Institutional Equity
$5.20
-1.14% 1D
Market Cap
$536.6M
1M Return
-9.25%
1Y Return
-14.61%
Forward P/E
N/M
Unified AI Score
43.7 / 100
HOLD
Tech 60.0
Fund 56.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
GRX +11.49%
GUT -14.61%
Spread: +26.1 pp (GRX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
GRX TTM Op. Margin: N/A
GUT TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GRX vs GUT. Trailing 12-month operating profitability (GRX N/A vs GUT N/A) and valuation multiples (GRX N/M vs GUT N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | GRX | GUT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $142.9M | $536.6M | Larger Scale | GUT |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 91% ($9โ$11) | 8% ($5โ$7) | Stronger Trend | GRX |
| Beta / 30D Volatility Risk Regime | 0.14ฮฒ ยท 14% Vol | 0.28ฮฒ ยท 27% Vol | Lower Realized Risk | GRX |
| Unified Institutional Score Composite Signal | 44.3 / 100 (HOLD) | 43.7 / 100 (HOLD) | Higher Composite | GRX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full GRX vs GUT Buy Guide
GRX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
GUT
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither GRX nor GUT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.